Featured Posts
JAMA Study on Price of Diabetes Medicines is Deceiving and Threatens Medical Innovation
In a recent study by the activist-funded JAMA Network, researchers erroneously “determined” that the price of diabetes medicines, like insulins, SGLT2 inhibitors, and…
Commentary
Biden Budget Would Expand Devastating Drug Price Controls
President Biden’s new proposed budget for Fiscal Year 2025 calls for an expansion of the drug price controls passed in the Inflation Reduction Act (IRA). These…
Commentary
ATR Supports Bipartisan Bill that Expands Health Savings Accounts
In February, the House of Representatives placed H.R.5688, the Bipartisan HSA Improvement Act, on the Union Calendar making it eligible for floor consideration. This recent movement…
Commentary
Filtered Posts
ATR Joins Coalition in Support of Site-Neutral Payments
Commentary
S.127 Would Increase the Deficit by Tens of Billions of Dollars
Commentary
Biden Budget Expands Disastrous Price Controls on Medicine
Commentary
Sen. Cruz is Right to Urge Caution on Giving FTC New Power to Regulate
Commentary
Senate Should Reject S. 150, Legislation That Would Stunt Medical Innovation
Commentary
ATR Supports Senator Lee’s Bill to Roll Back Biden’s Drug Price Controls
Commentary
Poll: Canadians Significantly Less Confident in Their Healthcare System Than Americans
Commentary
STUDY: Drug Price Controls Will Actually Raise Health Costs
Commentary
Drug Price Controls Will Cost Lives, Not Save Them
Commentary
Biden Isn’t “Negotiating” Drug Prices, He’s Forcing Price Controls Through Tax Hikes
Commentary